Clinical trial · Interventional
The COMPASSION Study
The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients With Metastatic Breast Cancer Receiving Hospice Care
NCT06507930CI-TRIAL-00096435recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Metastatic Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Unresectable Breast Carcinoma | Breast Carcinoma | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Telehealth Hospice Visits | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Usual Care Cohort
- description
- 25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone.
- type
- EXPERIMENTAL
- label
- Compassion Cohort
- description
- 25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone. * 4 weekly check-ins via Zoom or phone call with study team.
- interventionNames
- Other: Telehealth Hospice Visits
Primary outcomes (1)
- measure
- Proportion of Participant Intervention Completion
- timeFrame
- Up to 4 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient of any gender with unresectable locally advanced or metastatic breast cancer * Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice \</= 1 week before enrollment * Ability to conduct video or phone check-ins, even if assistance required. * Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able * Hospice setting is within Massachusetts * Non-English language allowed but interpreter services must be present at each meeting and will be coordinated by scheduling team * Willingness to provide a caregiver/loved one's contact information for survey contact at 4 weeks after enrollment Exclusion Criteria: * Unable to provide verbal consent * Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting) * Hospice setting outside of Massachusetts * Individuals who are under the age of 18, as this is not a project focused on pediatric patients.
References
Publications (0)
Data not yet available
No reference posted for this study.